EBR Systems, Inc. is engaged in the treatment of patients suffering from cardiac rhythm...EBR Systems, Inc. is engaged in the treatment of patients suffering from cardiac rhythm diseases by providing physiological stimulation through endocardial pacing. It is a medical device company developing the wireless stimulation endocardially cardiac resynchronization therapy (WiSE CRT) System, an implantable cardiac pacing system that stimulates endocardial heart tissue to correct heart rhythm conditions without using leads. This investigational device delivers left-ventricle endocardial pacing for CRT without wires or leads. The WiSE CRT System developed a new approach to cardiac pacing, aiming to transform CRT delivery and benefit patients who have not succeeded with conventional CRT. It operates wholly owned subsidiaries in Australia (EBR Systems (AUST) Pty Ltd) and the United Kingdom (EBR Systems (UK) Limited), which conduct clinical trials and work on intellectual property development in their respective regions.More
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.